Molecular Pituitary Imaging Using 18F-FET PET
Recruiting
N/A
Interventional Study
Pituitary Adenoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 100
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 20 (estimated)
- Sponsor
- University of Cambridge · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this single centre pilot study is to explore whether 18F-fluoro-ethyl-tyrosine PET (FET-PET) yields comparable findings to 11C-methionine PET (Met-PET) for the localisation of pituitary tumours.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria
* Participant is willing and able to give informed consent for participation in the study
* Male or female, age 18 or above
* Presence of pituitary adenoma suspected on the basis of clinical/biochemical and/or radiological findings
* Previous 11C-Met-PET/CT
Exclusion criteria
*…
Contacts